John Karanicolas is the Head of Computational Drug Discovery at AbbVie, a position they have held since 2024. Prior to this, they served as a Professor at Fox Chase Cancer Center from 2019 to 2024 and held the role of Assistant Professor at the University of Kansas from 2008 to 2016.
This person is not in the org chart
This person is not in any teams
This person is not in any offices